Cryptosporidiosis worsened in mice on probiotics

August 31, 2018, American Society for Microbiology

In an unexpected research finding infections with the intestinal parasite, Cryptosporidium parvum, worsened in mice that had been given a probiotic. The research was published in Applied and Environmental Microbiology, a journal of the American Society for Microbiology.

As compared to control mice, the probiotic-consuming mice excreted more parasites in their feces, and their intestinal microflora were different from those of the control mice. However, both sets of microflora were composed of genera that normally are present in the gut, and the mechanisms responsible for the observed probiotic effect are unclear, said corresponding author, Giovanni Widmer, Ph.D., whose graduate student, Bruno Oliveira, ran the experiments.

Contrary to expectations, "we found that consumption of a commercially available probiotic actually increased the severity of the infection," said Dr. Widmer, who is Professor of Infectious Disease & Global Health, Cummings School of Veterinary Medicine, Tufts University, North Grafton, MA.

Cryptosporidiosis is a major cause of infant diarrhea in developing nations. It killed an estimated 48,000 people worldwide in 2016, and caused the loss of more than 4.2 million disability-adjusted life-years, according to The Lancet, a medical journal. There are neither drugs to treat cryptosporidiosis, nor vaccines to prevent it. (image: high magnification micrograph of cryptosporidium infection, Wikimedia Commons)

Antibiotics, which often perturb or even deplete the normal intestinal microbiota, can thus render individuals more vulnerable to . Conversely, a healthy microbiome can prevent such infections, or reduce their severity. Reasoning along these lines, the researchers posited that a containing live microorganisms that are found in healthy intestines could reduce the severity of cryptosporidiosis in a mouse model.

"Mitigating the disease's severity may be sufficient to prevent diarrhea, or shorten its duration, and enable the immune system to naturally control the infection," said Dr. Widmer.

Despite an outcome that was contrary to the working hypothesis, the results demonstrate that it may be possible to develop probiotics to mitigate cryptosporidiosis. Prior to the experiment, "we didn't know if cryptosporidium growth in the gut could be affected by diet," said Dr. Widmer. "The goal is now to find a mechanistic link between microflora and cryptosporidium proliferation, and ultimately design a simple nutritional supplement which helps the body fight the ."

"Identifying specific mechanisms that alter pathogen virulence in response to diet may enable the development of simple pre- or probiotics capable of modifying the composition of the microbiota to reduce the severity of cryptosporidiosis," said Dr. Widmer.

Explore further: Scientists attack a potentially fatal infection that hits young children in the developing world

Related Stories

Scientists attack a potentially fatal infection that hits young children in the developing world

December 2, 2015
A gastrointestinal parasite that causes serious diarrhea and malnutrition in infants and toddlers could well meet its demise in Saul Tzipori's laboratory at Tufts University.

Scientists find new cultivation system to battle parasite causing diarrhoea

December 4, 2017
A research team at the University has established the first long-term cultivation system at a laboratory scale for the parasite Cryptosporidium, one of the world's worst and most common causes of diarrhoea and death from ...

Progress reported in global fight against diarrheal disease cryptosporidiosis

May 31, 2017
Infectious disease scientists from Novartis, the University of Georgia and Washington State University have reported the discovery and early validation of a drug candidate for treating cryptosporidiosis, a diarrheal disease ...

Promising modification of the intestinal flora in colon cancer

September 25, 2017
Living lactic acid bacteria, probiotics, can change the intestinal flora of patients with cancer of the colon. These are the findings of a study published in the journal BMJ Open Gastroenterology.

Role of oral microbiota in the severity of chemotherapy-induced oral mucositis

July 26, 2018
At the 96th General Session of the International Association for Dental Research (IADR), held in conjunction with the IADR Pan European Regional (PER) Congress, Kai Soo Tan, National University of Singapore, gave a oral presentation ...

Recommended for you

A new approach to developing a vaccine against vivax malaria

September 21, 2018
A novel study reports an innovative approach for developing a vaccine against Plasmodium vivax, the most prevalent human malaria parasite outside sub-Saharan Africa. The study led by Hernando A. del Portillo and Carmen Fernandez-Becerra, ...

Pre-clinical success for a universal flu vaccine offers hope for third generation approach

September 21, 2018
Researchers from the University of Oxford's Department of Zoology have demonstrated pre-clinical success for a universal flu vaccine in a new paper published in Nature Communications.

Researchers define possible molecular pathway for neurodegeneration in prion diseases

September 21, 2018
A new study has shed light on the mechanisms underlying the progression of prion diseases and identified a potential target for treatment.

Fighting a deadly parasite: Scientists devise a method to store Cryptosporidium, aiding vaccine research efforts

September 21, 2018
In May, just before one of the hottest summers on record, the U.S. Centers for Disease Control and Prevention issued a warning about diseases lurking in recreational water facilities like swimming pools and water playgrounds. ...

Scientists make significant discovery in the fight against drug-resistant tuberculosis

September 20, 2018
A team of scientists have identified a naturally occurring antibiotic that may help in the fight against drug-resistant Tuberculosis.

Anti-cancer drugs may hold key to overcoming antimalarial drug resistance

September 20, 2018
Scientists have found a way to boost the efficacy of the world's most powerful antimalarial drug with the help of chemotherapy medicines, according to new research published in the journal Nature Communications.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.